Treatment Options for Morning Sickness
Diet and lifestyle modifications should be the initial steps in managing morning sickness, followed by ginger and vitamin B6 as first-line pharmacologic options, with doxylamine and H1-receptor antagonists as effective second-line treatments for persistent symptoms. 1
Understanding Morning Sickness
- Nausea and vomiting of pregnancy (NVP) affects approximately 70-90% of pregnant women, typically beginning at 4-6 weeks, peaking at 8-12 weeks, and subsiding by week 20 1
- The condition is associated with elevated levels of human chorionic gonadotropin, estrogen, and changes in gastrointestinal motility 1
- Severity can be assessed using the Motherisk Pregnancy-Unique Quantification of Emesis (PUQE) score, which helps guide treatment decisions 1
First-Line Treatment: Non-Pharmacological Approaches
Dietary Modifications
- Eat small, frequent, bland meals (BRAT diet: bananas, rice, applesauce, and toast) 1
- Focus on high-protein, low-fat meals 1
- Avoid spicy, fatty, acidic, and fried foods 1
- Consume foods at room temperature rather than hot to minimize strong odors 2
Lifestyle Changes
- Identify and avoid specific triggers, including foods with strong odors or activities that worsen symptoms 1
- Ensure adequate hydration throughout the day 2
- Consider dietary consultation for persistent symptoms 2
First-Line Pharmacological Treatment
Vitamin and Herbal Options
- Ginger (250 mg capsules 4 times daily) - recommended by American College of Obstetricians and Gynecologists (ACOG) 1
- Vitamin B6 (pyridoxine, 10-25 mg every 8 hours) - recommended by ACOG 1
Second-Line Pharmacological Treatment
Antihistamines
- H1-receptor antagonists (doxylamine, promethazine, dimenhydrinate) are considered safe first-line pharmacologic antiemetic therapies 1
- Doxylamine is FDA-approved and recommended by ACOG for persistent NVP refractory to non-pharmacologic therapy 1
- Doxylamine and pyridoxine combination (available in 10 mg/10 mg and 20 mg/20 mg formulations) is safe and well-tolerated 1
Management of Hyperemesis Gravidarum
- Hyperemesis gravidarum (HG) affects 0.3-2% of pregnant women and represents a severe form of NVP 1, 3
- Characterized by intractable vomiting leading to dehydration, weight loss >5% of pre-pregnancy weight, and electrolyte imbalances 1
- Treatment may require:
Treatment Algorithm
Mild NVP (PUQE score ≤6):
Moderate NVP (PUQE score 7-12):
Severe NVP/HG (PUQE score ≥13):
Important Considerations
- Early intervention is crucial as treatment in early stages may prevent progression to hyperemesis gravidarum 5, 6
- Pregnant women often hesitate to seek treatment due to concerns about medication safety during pregnancy 5, 6
- The woman's perception of symptom severity plays a critical role in treatment decisions 5
- Always rule out other causes of nausea and vomiting before attributing symptoms to pregnancy 5